Leafy Green Veggies Set Omega-6 on Fire? Plus: Proprietary but Worth Mentioning Milk Protein Contrate for Knee Pain
If you follow @SuppVersity on Facebook, you will know the peer-reviewed open access journal “Nutrients” – they publish a lot of interesting papers every month and some even make it from the short news on Facebook to an actual full-length article on the SuppVersity – two studies did just that, today: A study by Johnson et al. with the potential to (eventually unwarrantedly) spoil your appetite for leafy greens and an RCT by Ziegenfuss et al. you should know if you want to stay on top of the research on “joint supplements”… joint supplements that seem to work even for people with minor (=non-osteoporotic) ailments.
- Omega-6/3 ratio and how its ill effect seem to be mitigated by collard greens (CG), purslane (PL) and orange flesh sweet potato greens (SPG) — Johnson 2019
Eating way too much vegetable and seed-oils that are high in omega-6 and low in omega-3? Then, you’re like one o the rats in a recent study from the Tuskegee University who were randomly assigned to a 25:1 ω-6:ω-3 diet with 4% (green leafy vegetables =GLVs, dried weight) of either collard greens (CG), purslane (PL), or orange flesh sweet potato greens (SPG) CG, PL or SPG.
Dietary intake, body weight, blood pressure, plasma adiponectin, high sensitivity C-reactive protein (hsCRP), oxygen radical absorbance capacity and lipid profile were determined using standardized procedures. Following a 6-week consumption period, systolic blood pressure, plasma adiponectin, total and low-density lipoprotein (LDL) cholesterol decreased following the consumption of diets containing GLVs.
|While the food intake was hardly different, the rats on all high N6:N3 diets weighed 13-15% more than peers on an unmodified AIN-76A (Johnson 2019).|
Warning: Pounding green leafy vegetables won’t keep you lean on your Westernized omega-6-super-charged diet… as the data from Johnson’s study indicates (see Figure on the left) even if you’re a mouse you’re gonna gain significantly more weight irrespective of added collard greens (CG), purslane (PL), or orange flesh sweet potato greens.
Moreover, it is no coincidence that those “extra pounds” are – in relative terms – in a similar range as the extra energy intake from the high(er) fat chow (440kcal/100g vs. 370kcal/100g) – in the end, for body weight, calories count… whether and to which extent that depends on the N6:N3 ratio will have to be tested using isocaloric diets in future studies.
Figure 1: GLVs lowered adiponectin, and – if anything – increased the overall inflammation as measured by hs-CRP (total antioxidant potential was lowered, too | Johnson 2019)
While hsCRP increased in the rodents receiving the high N6:N3 diets (see Figure 1) – interestingly enough, especially in those who received extra CG and PL… and as if that wasn’t bad enough, “the antioxidant capacity was significantly reduced (p < 0.05) with the consumption of diets containing the GLVs”, in other words:
Leaving out the green green leafy vegetables was a plus in terms of antioxidant defenses!
Against that background, it is unsurprising that plasma adiponectin levels (the anti-inflammatory were significantly reduced (p < 0.05) among the rodents consuming the PL (29.5 μg/mL) diet versus those consuming the AIN-76A (43.0 μg/mL) and C (38.6 μg/mL) diets, too.
The authors still recommend eating leafy greens! And so do I!
Yet, our rationale differs: Johnson et al. posit that “CG, PL and SPG have the potential to decrease risks for cardiovascular disease (CVD)” (Johnson 2019), as both have been linked not just to inflammation (which clearly didn’t improve, here, but also and specifically to blood lipids and blood pressure in mammals.
The claim seems all the more warranted in view of the fact that collard greens, purslane, and sweet potato greens prevented both high blood pressure, and dyslipidemia (i.e., hypercholesterolemia, hypertriglyceridemia) in the spontaneously hypertensive rats in the study at hand. More, specifically…
“[…a]t week 6, consumption of the CG (173.4 mmHg) diet resulted in a decrease (p < 0.05) in systolic blood pressure compared to the AIN-76A (181.4 mmHg) and control (181.1 mmHg) diets. Among SHRs consuming diets containing GLVs, CG were able to modulate slightly greater non-significant decreases in systolic blood pressure in comparison to PL and SPG” (
Furthermore, the scientists’ analysis of the blood lipids showed that …
“In comparison to the control diet (97.0 mg/dL), triglyceride levels were increased among SHRs consuming the PL (113.0 mg/dL) and SPG (118.4 mg/dL) diets and decreased following the consumption of the CG diet (92.2 mg/dL) [Plus:] Although not significant, total cholesterol and LDL-C + VLDL-C levels were decreased among SHRs consuming the CG, PL and SPG diets in comparison to the AIN-76A and control diets [and] in comparison to the control diet (33.7 mg/dL), levels of HDL-C were increased among SHRs consuming the CG (38.7 mg/dL) and PL (41.3 mg/dL) diets” (
Johnson et al. are also right to point out: “In addition to CVD, risks associated with other diseases such as atherosclerosis, diabetes, cancer and other inflammatory conditions may potentially be reduced as well with the consumption of these vegetables” (Johnson 2019).
And still, I would like to add that the overall research in favor of the detrimental effects of exorbitant N6:N3 ratios and health benefits of all sorts of green leafy vegetables (outside of PUFA protection, btw, which would probably improve more with high vitamin E foods) indicates in my humble opinion that you would be best off if you normalized (N6:N3 < 6, total PUFA intake <20% energy intake) your intake of readily oxidizable polyunsaturated fats and ate a variety of green leafy vegetables on top of that 😉
- “Proprietary” is not exactly everyone’s favorite word when it comes to supplements, but when it’s used in the title of a paper that’s called “Proprietary Milk Protein Concentrate [MPC] Reduces Joint Discomfort While Improving Exercise Performance in Non-Osteoarthritic Individuals” (Ziegenfuss 2019) that’s still intriguing.
Milk? Yeah,… I know dairy is not exactly what you will think about ‘natural joint/arthritis prevention/treatment’. That’s however, partly due to the fact that you didn’t do your homework. As Ziegenfuss et al. point out, special forms of milk, such as skim milk powder from hyperimmunized cows can reduce cholesterol (Golay 1990) and inflammation (Omrod 1991 & 92) – problem: inconvenient, tastes like crap, don’t solve well, etc.
|In vitro data from the previously cited study by Ormrod & Miller suggests that MPC exerts its by immuno-modulating effects – more precisely, by suppressing the ability of neutrophils to emigrate from the vasculature into cartilage and co (Ormrod 1992).|
Glucosamine and Milk Protein Concentrate (#MPC) – alternatives, complements, or synergists? Even though their efficacy is still debated, glucosamine supplements are the go-to supplement for people with knee pain and have at least some scientific back-up for their efficacy (Knapik 2018). Hence, the obvious question is: Should I take one or the other or both?
In the present study, on the other hand, Ziegenfuss et al. did not observe significant changes in COMP from MPC supplementation, which is not actually a surprise, though – after all, the subjects didn’t train or sustain otherwise induced wear-and-tear on the knee joint in form of high volumes of endurance training.
In the absence of other news on the mechanism, we do thus simply have to assume that MPC works due to its high concentration of immune factors and could work both, additively and/or synergistically w/ glucosamine. On the other hand, it seems rather unlikely that one will cancel out the effects of the other and/or offer absolutely zero extra-benefit… note: this benefit may, however, very well be clinically irrelevant :-/
- … sounds like manageable obstacles, doesn’t it? I guess that’s what Colker et al. (2002) et al. also thought when “[t]o address these shortcomings”, they developed the previously mentioned “proprietary (lactose-free) milk protein concentrate” from milk produced in hyperimmunized cows in (a) way(s) that will retain “much of the valuable high-molecular-weight immunoglobulins and low-molecular-weight bioactives while removing much of the carbohydrate, salt and fat resulting in its ability to be concentrated and encapsulated”. To examine its effects, Colker et al. (2002) conducted a randomized, double-blind study, in which 31 adults with physician-diagnosed osteoarthritis in their knees, received either a placebo or said concentrated milk protein (12 oz daily).
Figure 2: Relevant outcomes of Coker’s 2002 study comparing 12oz/d of the “proprietary (lactose-free) milk protein concentrate” from milk produced in hyperimmunized cows to placebo (Colker 2002).
As the data in Figure 2 shows, a significant treatment effect was observed in the WOMAC, knee pain score, sports function and quality of life for those participants who consumed the concentrated milk protein while only improvements in sports function and quality of life were found in the placebo group.
- Follow-up studies yielded similarly beneficial results, but all of them were conducted in patients with pre-existing osteoarthritis; and, as Ziegenfuss et al. highlight: “[B]eyond markers of clinical safety, neither study reported on any biomarkers that might help to offer any insight into potential mechanism(s) of action” (Ziegenfuss 2019) – reason enough to conduct another follow-up study to …
“examine the impact of ingesting [said] concentrated milk protein derived from the milk produced by hyperimmunized cows on alleviating pain (discomfort) and function with and without an external physical stimulus in non-osteoarthritic participants who reported having mild to moderate functional knee pain during/after physical activity [and to] examine changes in physical performance and a biomarker of cartilage breakdown” (Ziegenfuss 2019).
For many athletes who fall into the same category of “non-osteoarthritic participants who [report] having mild to moderate functional knee pain”, defined as a rating of 30/100 or higher on a 100-mm visual analog scale for knee discomfort, the results of the study are intriguing (see Figure 3).
Unlike previous studies, Ziegenfuss et al. used capsules to deliver the 4000 milligrams of a proprietary milk protein concentrate from hyperimmunized cows (or a placebo) in a randomized, double-blind fashion. Subjects took one dose (5 capsules totaling 2000 mg) in the morning and one dose (5 capsules totaling 2000 mg) in the evening with 12 fluid ounces of cold tap water. In that, it is remarkable, ’cause unfortunately by no means common practice that the “[s]upplement purity and potency was confirmed by a third party (independent) laboratory” (Ziegenfuss 2019).
- Overall the data (see Figure 3 & 4) seem to suggest that – assuming that you get a similarly pure/potent product – using the product from Stolle Milk Biologics who also sponsored the study with an external grant, may constitute an alternative for (or adjunct to?) standard supplements such as glucosamine (cf. comparison of MPC w/ glucosamine by Zenk et al. 2002)… and, the only unexpected ‘side effect’ was an MPC-induced reduction of the subjects’ back and neck pain.
However, as the authors readily admit, the results “are specific to a middle-aged population with no resting knee pain, no previous diagnosis of joint disease and only mild to moderate joint pain with physical exertion” and thus not suitable for uncritical extrapolation of the findings to other populations. The study also failed to provide conclusive evidence as to the underlying mechanisms and the effect of long-term supplementation (16-24 weeks).
- Atukorala, Inoshi, et al. “Is there a dose‐response relationship between weight loss and symptom improvement in persons with knee osteoarthritis?.” Arthritis care & research 68.8 (2016): 1106-1114.
- Colker, Carlon M., et al. “Effects of a milk-based bioactive micronutrient beverage on pain symptoms and activity of adults with osteoarthritis: a double-blind, placebo-controlled clinical evaluation.” Nutrition 18.5 (2002): 388-392.
- Neidhart, M., et al. “Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.” Osteoarthritis and Cartilage 8.3 (2000): 222-229.
- Ormrod, D. J., and T. E. Miller. “The anti-inflammatory activity of a low molecular weight component derived from the milk of hyperimmunized cows.” Agents and Actions 32.3-4 (1991): 160-166.
- Ormrod, Douglas J., and Thomas E. Miller. “A low molecular weight component derived from the milk of hyperimmunised cows suppresses inflammation by inhibiting neutrophil emigration.” Agents and actions 37.1-2 (1992): 70-79.
- Petersen, Susanne Germann, et al. “Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training.” Osteoarthritis and Cartilage 18.1 (2010): 34-40.
- Zenk, John L., Tami R. Helmer, and Michael A. Kuskowski. “The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: an exploratory, randomized, double-blind, placebo-controlled trial.” Current Therapeutic Research 63.7 (2002): 430-442.